CSIMarket
 


Carlisle Companies Incorporated  (CSL)
Other Ticker:  
 


Carlisle Companies Incorporated's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Carlisle Companies Incorporated's ROI in the third quarter of 2023?
Carlisle Companies Incorporated achieved a return on average invested assets (ROI) of 13.91 % in its third quarter of 2023, this is above CSL's average return on investment of 10.23%.
Carlisle Companies Incorporateds investments during the 12 months ending in the third quarter of 2023 are valued at $5 billion

ROI has improved compared to 13.63% in the second quarter of 2023, due to net income growth.

Within the Healthcare sector 70 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 157 to 586.

Definition and Formula of Return on Investment


Return On Investment (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Investment Change -2.16 % -12.34 % -9.22 % -8.95 % -
Y / Y Net Income Change 4.28 % -35.46 % -47.47 % 35.99 % 79.24 %
Investment (TTM) in Millions 5,207 5,314 5,340 5,306 5,322
Return On Investment (TTM) 13.91 % 13.63 % 15.11 % 16.37 % 15.21 %
CSL's Overall Ranking # 586 # 157 # 571 # 138 # 408
Seq. Investment Change -2.02 % -0.49 % 0.65 % -0.3 % -12.21 %
Seq. Net Income Change 36.49 % 91.35 % -41.62 % -31.61 % -15.52 %
Net Income (TTM) in Millions 736 725 832 924 878




Return On Investment CSL's Ranking
Within: No.
Industry # 15
Sector # 71
Overall # 586

Return On Investment Statistics
High Average Low
15.65 %
10.23 %
6.01 %
(Dec 31 2022)   (Mar 31 2021)







Financial Statements
Carlisle Companies Incorporated's III. Quarter Investments $ 5,207 Millions CSL's Balance sheet
Carlisle Companies Incorporated's III. Quarter Income $ 266 Millions Quarterly CSL's Income Statement
CSL's Income by Division See CSL's Income by Division


CSL Annual Return On Investment (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Investments in Millions 5,306 5,827 4,984 4,377 4,452
Y / Y Investment Growth -8.95 % 16.91 % 13.89 % -1.69 % -4.08 %
Net Income in Millions 924 422 320 473 611
Y / Y Net Income Growth 119.11 % 31.74 % -32.3 % -22.63 % 67.2 %
Annual Return On Investment 17.41 % 7.24 % 6.42 % 10.8 % 13.73 %


Annual Roi Comment
In the fiscal year 2022 ROI improved to 17.41 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CSL's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for CSL's Competitors
Roi for Carlisle Companies Incorporated's Suppliers
Return On Investment for CSL's Customers

Other Ratios
CSL's Roa CSL's Inventory Turnover Ratio CSL's Growth Rates CSL's Dividend Statistics
CSL's Profitability Ratios CSL's Asset Turnover Ratio CSL's Dividend Growth
CSL's Roe CSL's Valuation Ratios CSL's Financial Strength Ratios CSL's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Enzo Biochem Inc  38.07 %
Malachite Innovations Inc   37.82 %
Mettler toledo International Inc   37.29 %
Cortexyme Inc   36.76 %
Fusion Pharmaceuticals Inc   35.64 %
Singular Genomics Systems Inc   31.10 %
Semler Scientific Inc   30.96 %
National Research Corporation  30.72 %
Synaptogenix Inc   30.24 %
Denali Therapeutics Inc   29.23 %
Shockwave Medical Inc   28.94 %
Vaso Corporation  28.94 %
Arcturus Therapeutics Holdings Inc   28.09 %
Innoviva Inc   26.53 %
Johnson and Johnson  25.73 %
Protalix Biotherapeutics inc   25.29 %
Exagen Inc   24.03 %
Harmony Biosciences Holdings inc   23.58 %
Voyager Therapeutics Inc   23.09 %
Iradimed Corporation  21.83 %
Vertex Pharmaceuticals Inc  20.88 %
Point Biopharma Global Inc   20.60 %
Bellicum Pharmaceuticals Inc   19.61 %
Chemed Corporation  18.89 %
Rapid Micro Biosystems Inc   18.67 %
Zoetis Inc   18.66 %
Corcept Therapeutics Inc  18.61 %
Macrogenics Inc   18.47 %
Edwards Lifesciences Corporation  18.40 %
West Pharmaceutical Services Inc   17.67 %


Date modified: 2023-10-28T10:22:12+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com